1. Home
  2. BIAF vs YYAI Comparison

BIAF vs YYAI Comparison

Compare BIAF & YYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • YYAI
  • Stock Information
  • Founded
  • BIAF 2014
  • YYAI 2015
  • Country
  • BIAF United States
  • YYAI Hong Kong
  • Employees
  • BIAF N/A
  • YYAI N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • YYAI
  • Sector
  • BIAF Health Care
  • YYAI
  • Exchange
  • BIAF Nasdaq
  • YYAI NYSE
  • Market Cap
  • BIAF 12.2M
  • YYAI 13.7M
  • IPO Year
  • BIAF 2022
  • YYAI N/A
  • Fundamental
  • Price
  • BIAF $0.35
  • YYAI $2.53
  • Analyst Decision
  • BIAF Hold
  • YYAI
  • Analyst Count
  • BIAF 1
  • YYAI 0
  • Target Price
  • BIAF N/A
  • YYAI N/A
  • AVG Volume (30 Days)
  • BIAF 12.3M
  • YYAI 2.0M
  • Earning Date
  • BIAF 08-13-2025
  • YYAI 09-09-2025
  • Dividend Yield
  • BIAF N/A
  • YYAI N/A
  • EPS Growth
  • BIAF N/A
  • YYAI N/A
  • EPS
  • BIAF N/A
  • YYAI N/A
  • Revenue
  • BIAF $8,809,228.00
  • YYAI N/A
  • Revenue This Year
  • BIAF N/A
  • YYAI N/A
  • Revenue Next Year
  • BIAF $20.00
  • YYAI N/A
  • P/E Ratio
  • BIAF N/A
  • YYAI N/A
  • Revenue Growth
  • BIAF 78.40
  • YYAI N/A
  • 52 Week Low
  • BIAF $0.16
  • YYAI $0.35
  • 52 Week High
  • BIAF $2.99
  • YYAI $16.90
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 56.35
  • YYAI 89.71
  • Support Level
  • BIAF $0.27
  • YYAI $0.84
  • Resistance Level
  • BIAF $0.38
  • YYAI $1.48
  • Average True Range (ATR)
  • BIAF 0.04
  • YYAI 0.24
  • MACD
  • BIAF 0.01
  • YYAI 0.16
  • Stochastic Oscillator
  • BIAF 73.43
  • YYAI 75.45

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About YYAI CONNEXA SPORTS TECHNOLOGIES IN

Connexa Sports Technologies Inc operates in the sports equipment and technology business. It is a connected sports company delivering products, technologies, and services across the Watch, Play, Learn commercial and subscription-as-a-service activities in sports. The company's offerings include Slinger Launcher, which is comprised of a portable tennis ball launcher, a portable padel tennis ball launcher, and a portable pickleball launcher. Through Gameface, it provides AI technology and performance analytics.

Share on Social Networks: